New haemophilia drug Elocta approved in EuropeElocta, a new drug co-marketed by Sobi and Biogen, has been approved in the European Union. The injectable Share XNew haemophilia drug Elocta approved in Europehttps://pharmaphorum.com/news/new-haemophilia-drug-elocta-approved-in-europe/
